CRANBURY, N.J., Oct. 17, 2019 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) announced that John Dodd, Ph.D., Palatin's Vice President of Pre-Clinical Development, provided a ...
Conference participation by H2Ocean highlighted the role of sea salt based formulations in addressing oral complications of chemotherapy and radiation therapy. Innovation in supportive oncology care ...
TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRE: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio of assets and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results